CORE--HISTOLOGY AND IMMUNOCHEMISTRY

$0P01FY2001CANIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

Paper 32705545 Paper 26923594 Paper 24670685 Paper 24244613 Paper 23737486 Paper 23408103 Paper 22974392 Paper 22471706 Paper 22123186 Paper 21945077 Paper 21878538 Paper 21541704 Paper 21459801 Paper 21447808 Paper 21276786 Paper 21204711 Paper 21138857 Paper 20860838 Paper 20545610 Paper 20451654 Paper 20392877 Paper 20130264 Paper 20082448 Paper 20054865 Paper 19949842 Paper 19936989 Paper 19703301 Paper 19637041 Paper 19533338 Paper 19487454 Paper 19297414 Paper 19267898 Paper 19137425 Paper 19118050 Paper 18922113 Paper 18757322 Paper 18563554 Paper 18556345 Paper 18425577 Paper 18404683 Paper 17996864 Paper 17662267 Paper 17470737 Paper 17374994 Paper 17296734 Paper 17287253 Paper 17030631 Paper 17008703 Paper 16912158 Paper 16826579 Paper 16740736 Paper 16709615 Paper 16541323 Paper 16469769 Paper 16467123 Paper 16467118 Paper 16244788 Paper 16234531 Paper 16172443 Paper 16145046 Paper 15987438 Paper 15867374 Paper 15837971 Paper 15830138 Paper 15798188 Paper 15755967 Paper 15714204 Paper 15569979 Paper 15355892 Paper 15241819 Paper 15084238 Paper 15071073 Paper 14973381 Paper 14734488 Paper 12750263 Paper 12743151 Paper 12635133 Paper 12618500 Paper 12562650 Paper 12548595 Paper 12538499 Paper 12429135 Paper 12123539 Paper 12039951 Paper 12013530 Paper 12001107 Paper 11773287 Paper 11770293 Paper 11493692 Paper 11449403 Paper 11389920 Paper 11350726 Paper 11325822 Paper 11207044 Paper 10963646 Paper 10945602 Paper 10784631 Paper 10749910 Paper 10707955 Paper 10690547

Abstract

Histopathology (especially subtyping and grading of tumors) and immunohistochemistry (IHC) play a central role in the experimental designs of nearly every component of this Program Project. The purpose of this Core is therefore to provide large-scale histopathological and IHC evaluation of premalignant and malignant breast lesions to five Projects. Overall this effort will involve cutting, staining, and (most important) interpreting nearly 26,000 slides, and we feel that the core is necessary to ensure cost efficiency and uniformity of results for this immense workload. We have the necessary laboratory space, equipment, tumors, and especially human resources to make this centralized approach work successfully and productively -- during the previous funding period, this core component analyzed 16 separate markers and over 20,000 slides for Program Project investigations.

View original record on NIH RePORTER →